Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research    » Alternative Medicine    » Beta Cells    » Cause    » Cells    » Children    » Complications    » Control    » Cure    » Diagnosis    » Drugs    » Elderly    » Genes    » Immune Cells    » Inhaled Insulin    » Insulin    » Islet Cells    » Neuropathy    » Obesity    » Oral Insulin    » Other Diseases    » Pets    » Pre-Diabetes    » Prevention    » Research    » Retinopathy    » Risk Factors    » Stem Cells    » Technology    » Testing    » Transplants    » Treatments    » Trials    » Type 1    » Type 2 Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Research » Inhaled Insulin

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

MannKind Corporation Will Submit for FDA Approval for It’s SUPRA Inhaled Insulin Posted: Thursday, February 08, 2007

It has been described by Jay Skyler, a leading diabetologist, as the first in a new class of diabetic therapies, "Supra-Rapid Acting Insulin’s", that can change the way diabetes is treated.

Nasal Insulin Expands Trial for Postpranidal Hyperglycemia Indication Posted: Thursday, December 07, 2006

Bentley Pharmaceuticals, Inc., announced that, following successful review of its Investigational New Drug (IND) application by the FDA, a phase II program is now in effect and under way evaluating Bentley's human recombinant Intranasal Insulin Spray for the treatment of postprandial hyperglycemia in diabetics.

Nasal Insulin Spray Moving Forward with Phase 2 Trials Posted: Thursday, November 30, 2006

Two earlier studies conducted in Ireland with normal subjects and Type I diabetic patients demonstrated rapid absorption from the nasal spray and the expected glucose response.

New DPP-4 and Glitazone Diabetes Drugs Will Account for 72% of the Diabetes Mark Posted: Thursday, October 05, 2006

According to a new report from Decision Resources, the New Novel Drug Classes Will Account for 76% of the Type 2 Diabetes Market by 2020, even though they are not even available in the US at this time.

Snuff It or Puff It: Rapid Acting Insulin Nasal Spray Begins New Study Posted: Thursday, September 28, 2006

A new pharmacokinetic study to compare Nastech's intranasal insulin to injectable insulin and Exubera(R) (insulin human [rDNA origin]) Inhalation Powder, is set to begin.

Exubera Works Even with Cold or Flu-Study Posted: Thursday, September 21, 2006

A new form of insulin which is inhaled rather than injected works even if patients have a respiratory infections or are exposed to passive cigarette smoke.

MannKind Inhaled Insulin Matches Injections -Study Posted: Thursday, September 21, 2006

An inhaled insulin being developed by MannKind Corp produces comparable improvements in blood sugar control to rapid-acting insulin analog (RAA) given by injection, researchers said on Saturday.

Inhaled Insulin Effective Therapy for Poorly Controlled Type 2 Diabetes Posted: Thursday, August 17, 2006

Inhaled human insulin (Exubera) is as effective as glibenclamide as adjunctive therapy in patients with type 2 diabetes.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.